Bristol Unveils Post-Celgene Leadership Team, With Big R&D Changes
Executive Summary
Novartis's Hirawat will join the company as chief medical officer, while Celgene's Vessey will head early research. Bristol's current chief scientific officer Lynch will leave the company in October.